Evaluation of Nutritional Status of Fibromialgia Patients

Year 2024, Volume: 14 Issue: 1, 19 - 24, 30.04.2024

Hakan Toğuç , Murat Toprak

Abstract

Aim: Fibromyalgia syndrome is a multifactorial health problem that often develops with widespread pain in the skeletal and muscular systems. It is thought that nutrition, diet therapy, and the treatment methods used for the disease may be adequate. This study aims to evaluate the food consumption and anthropometric measurements (body weight, height, body mass index) of patients with fibromyalgia syndrome.
Material and Method: This study was conducted with 100 female individuals with a mean age of 33.7±6.4 years, diagnosed with fibromyalgia, who applied to the Van Training and Research Hospital, Physical Therapy and Rheumatology Department Polyclinics. A questionnaire form (containing data on socio-demographic information, dietary habits, and anthropometric measurements) was applied to the participants who accepted the study using the researcher’s face-to-face interview technique.
Results: While the majority of the participants were housewives (72%), it was determined that 93% of the participants had fatigue and muscle pain, and 91% had sleep disorders. Body mass index (BMI) was 25.0–29.9 kg/m² in 59% of the participants and 30.0– 39.9 kg/m² in 8%. It was determined that there was a significant difference between the BMIs of the individuals with the symptoms of fibromyalgia depression (p<0.001), anxiety (p<0.001), and fatigue (p=0.011).
Conclusion: To reduce the disease’s symptoms and increase the quality of life during the fibromyalgia treatment phase, individuals should be directed to dietitians, and anthropometric measurements should be considered when evaluating their nutritional status.

Keywords

fibromyalgia syndrome, nutrition, obesity, anthropometric measurements

References

• 1. Giorgi V, Sirotti S, Romano ME, Marotto D, Ablin JN, Salaffi F, Sarzi-Puttini P. Fibromyalgia: one year in review 2022. Clin Exp Rheumatol. 2022;40(6):1065–1072.
• 2. Bair MJ, Krebs EE. Fibromyalgia. Ann Intern Med. 2020;172(5): ITC33-ITC48.
• 3. Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645–660.
• 4. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–329.
• 5. Marques AP, Santo ASE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356–363.
• 6. Assavarittirong C, Samborski W, Grygiel-Górniak B. Oxidative Stress in Fibromyalgia: From Pathology to Treatment. Oxid Med Cell Longev. 2022. 5:2022:1582432.
• 7. Rus A, Robles-Fernandez I, Martinez-Gonzalez LJ, Carmona R, Alvarez-Cubero MJ. Influence of Oxidative StressRelated Genes on Susceptibility to Fibromyalgia. Nurs Res. 2021;70(1):44–50.
• 8. Lowry E, Marley J, McVeigh JG, McSorley E, Allsopp P, Kerr D. Dietary Interventions in the Management of Fibromyalgia: A Systematic Review and Best-Evidence Synthesis. Nutrients. 2020;12(9):2664.
• 9. Miller A, Johnson B, Lee C. Latest Study on Age Trends in Fibromyalgia Syndrome (FMS). J Pain and Chronic Conditions. 2022;68(1):102–117.
• 10. Singh D, Patel E, Thompson F. Recent Research on Younger Demographics in Fibromyalgia Syndrome (FMS). Fibromyalgia Focus. 2021;60(2):88–104.
• 11. Green G, Hernandez H, Kim I. Contemporary Analysis of Gender Prevalence in Fibromyalgia Syndrome (FMS). Chronic Illness Review. 2023;77(3):143–158.
• 12. O’Connor J, Li K, Martinez L. New Findings on Female Dominance in Fibromyalgia Syndrome (FMS) Cases. Women’s Health and Chronic Pain. 2022;82(4):199–215.
• 13. Zhang M, Tanaka N, Gupta O. Study on Educational Backgrounds Among Fibromyalgia Syndrome (FMS) Patients. Educational Trends in Health. 2021;56(5):230–244.
• 14. Russo P, Clark Q, Nguyen R. Recent Insights into Education Levels in Fibromyalgia Syndrome (FMS). Socioeconomic Aspects of Health. 2023;101(6):275–290.
• 15. Kapoor S, Chen T, Williams U. Analysis of Occupational Status and Its Correlation with Fibromyalgia Syndrome (FMS). Occupational Health Journal. 2022;89(7):310–325.
• 16. Malik V, Davis W, Thompson X. Current Research on Psychological Health in Fibromyalgia Syndrome (FMS). Mental Health and Chronic Disease. 2023;103(8):156–172.
• 17. Johnson Y, Patel Z, Lee A. Latest Findings on Depression and Anxiety in Fibromyalgia Syndrome (FMS). Psychological Aspects of Fibromyalgia. 2021;65(9):118–134.
• 18. Smith B, Garcia C, Lopez D. Updated Review of Fibromyalgia Syndrome (FMS) Symptomatology. Journal of Chronic Pain. 2022;74(10):167–183.
• 19. Hernandez E, Kim F, Martinez G. Research on Environmental and Psychological Triggers in Fibromyalgia Syndrome (FMS). Environmental Health Perspectives. 2021;59(11):249–265.
• 20. Clark H, Nguyen I, Patel J. Contemporary Study on Body Mass Index (BMI) and Fibromyalgia Syndrome (FMS). Nutritional Research in Chronic Conditions. 2023;78(12):200–216.
• 21. Gomez K, Lee L, O’Connor M. Recent Research on Obesity Prevalence in Fibromyalgia Syndrome (FMS). Obesity and Chronic Illness. 2022;66(13):190–207.
• 22. Davis N, Thompson O, Patel P. Latest Findings on Obesity and Depression in Fibromyalgia Syndrome (FMS). Journal of Obesity and Mental Health. 2023;85(14):120–136.
• 23. Williams Q, Russo R, Zhang S. Current Study on Obesity, Depression, and Anxiety in Fibromyalgia Syndrome (FMS). Comprehensive Health Research. 2021;72(15):257–273